Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

How drug and soap commercials are manipulating you

Martha Rosenberg
Meds
October 5, 2024
Share
Tweet
Share

Having worked as a copywriter and creative director at some of the world’s top ad agencies, including McCann Erickson (now McCann Worldgroup), I am vehemently critical of new advertising. Why? I know the tricks and how they manipulate well — think the old TV series Mad Men.

Leading the list of ads that I hate are direct-to-consumer (DTC) drug ads which began in the late 1990s. I am especially critical of them because I personally attended medical school for a while.

DTC ads have become a primary ad revenue for news outlets and websites and people even enjoy them. But they sell diseases and create hypochondria and cyberchondria along with marketing a drug.

For example, few had ever heard of the diseases of EPI (exocrine pancreatic insufficiency) or nAMD (wet age-related macular degeneration) until ads that mention them came online. Previously, drugmakers advertised the obscure diseases of Shift Work Sleep Disorder and Non-24-hour Sleep Wake Disorder for the same reasons.

The symptoms that accompany the disease (see the online “symptom checker” if you have any doubts) are designed to create demand for an expensive new drug that has become available. (But I repeat myself! New drugs are always expensive until they go off patent.) Symptoms are often common, like fatigue, dry cough, or indigestion that anyone could have.

Once upon a time, doctors told patients that they were probably fine and should “take two aspirins and call me in the morning.” Now, thanks to DTC advertising, you are probably no longer fine. But if a patient self-diagnoses with the advertised disease and asks for the drug by name, the ad has done its job.

I do not just pick on drug ads. The current soap-related ads, running a close second with their reach and frequency, are just as manipulative. These ads now declare that your whole body smells (not just your feet, armpits, and private parts), that, in fact, you likely smell so badly that “odor transfer” is occurring in your own home, and that washing won’t remove the stench unless you buy the advertised products.

Soap product ads are very catchy, using popular music hooks and repetition like “It’s The Sheets.” One ad features a man following the “irresistible” scent of someone else on the street who has used the advertised product, like a romantic whodunit. Another feature is the sound of the laundry product dropping into a washer, calling it “music to your nose.”

But scented laundry detergent products are linked to cancer according to CBS and other sources.

Moreover, the Environmental Working Group warns that fragrance chemicals may be from phthalates “which are hormone disrupters linked to reproductive problems.”

Well-documented chemical risks are the reason that fragrances have been removed from many personal care products sold in grocery stores today, whose labels read “fragrance-free.” Why has the pendulum suddenly swung back?

While Downy leads the pack of new soap product ads, Tide ads are plentiful and just as offensive, at least to this ad woman. Ads for “Tide Free and Gentle,” for example, are said to be free of dyes and perfumes, like Tide’s non-Free and Gentle formula. In advertising, we call this playing of both sides of the street cross-selling.

And there’s another trick both drug and soap product ads use: add-on mania. Whatever product you are using–an antidepressant or a laundry detergent—might not be doing its job. But that doesn’t mean you should stop using the product. Add this new one we are advertising, and you will be OK, and so will we–we will double our money.

ADVERTISEMENT

Martha Rosenberg is a health reporter and the author of Big Food, Big Pharma, Big Lies and Born With a Junk Food Deficiency.  

Prev

Parents in crisis: How physicians can help

October 5, 2024 Kevin 0
…
Next

Radiologists need to be realistic about the job market

October 5, 2024 Kevin 0
…

Tagged as: Medications

Post navigation

< Previous Post
Parents in crisis: How physicians can help
Next Post >
Radiologists need to be realistic about the job market

ADVERTISEMENT

More by Martha Rosenberg

  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • How drug companies profit by inventing diseases

    Martha Rosenberg
  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg

Related Posts

  • Drug ads are a campaign against physician trust

    Judy Salz, MD
  • The complications of drug regulation

    Julie Craig, MD
  • Should drug use be decriminalized?

    Katya Korol and Sarah Fraser, MD
  • The promise of in silico drug development to improve patient outcomes

    Tanja Dowe
  • Drug advertising has helped created victim politics

    Martha Rosenberg
  • Before taking Paxlovid, consider these drug interactions

    Param Patel, PharmD

More in Meds

  • Pharmacy benefit manager reform vs. direct drug plans

    Leah M. Howard, JD
  • A cautionary tale about pramipexole

    Anonymous
  • My persistent adverse reaction to an SSRI

    Scott McLean
  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • How India-Pakistan tensions could break America’s generic drug pipeline

    Adwait Chafale
  • Most Popular

  • Past Week

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • Reimagining medical education for the 21st century [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
  • Recent Posts

    • Advance directives not honored: a wife’s story

      Susan Hatch | Conditions
    • Why billionaires dress like college students

      Osmund Agbo, MD | Physician
    • The therapy memory recall crisis

      Ronke Lawal | Conditions
    • A urologist explains premature ejaculation

      Martina Ambardjieva, MD, PhD | Conditions
    • Why medical organizations must end their silence

      Marilyn Uzdavines, JD & Vijay Rajput, MD | Policy
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • Reimagining medical education for the 21st century [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
  • Recent Posts

    • Advance directives not honored: a wife’s story

      Susan Hatch | Conditions
    • Why billionaires dress like college students

      Osmund Agbo, MD | Physician
    • The therapy memory recall crisis

      Ronke Lawal | Conditions
    • A urologist explains premature ejaculation

      Martina Ambardjieva, MD, PhD | Conditions
    • Why medical organizations must end their silence

      Marilyn Uzdavines, JD & Vijay Rajput, MD | Policy
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...